Menu

Blog

Archive for the ‘life extension’ category: Page 102

Jul 3, 2023

Grand Opening of our Research Center Expansion

Posted by in category: life extension

On January 23, 2023, we celebrated the expansion of the SENS Research Foundation’s Research Center, more than doubling its capacity.

California Dignitaries Alison Hicks, Mayor of Mountain View, Peter Katz, President of the Mountain View Chamber of Commerce, Marc Berman, California State Assemblymember, and Saul Miranda, District Representative, were present to officiate the ribbon-cutting ceremony.

Continue reading “Grand Opening of our Research Center Expansion” »

Jul 3, 2023

Dr. Aubrey de Grey, Ph.D. — President & Chief Science Officer, Longevity Escape Velocity Foundation

Posted by in categories: biotech/medical, life extension, science

Accelerating Effective Treatments To Prevent And Reverse Human Age-Related Disease — Dr. Aubrey de Grey, Ph.D. — President & Chief Science Officer, Longevity Escape Velocity Foundation (LEVF)


Dr. Aubrey de Grey, Ph.D., is President & Chief Science Officer of the Longevity Escape Velocity (LEV) Foundation (https://www.levf.org/), an organization focused on proactively identifying and addressing the most challenging obstacles on the path to the widespread availability of genuinely effective treatments to prevent and reverse human age-related disease.

Continue reading “Dr. Aubrey de Grey, Ph.D. — President & Chief Science Officer, Longevity Escape Velocity Foundation” »

Jul 3, 2023

How Long Until We Reverse the Clock? | Dr David Sinclair

Posted by in categories: innovation, life extension

https://youtube.com/watch?v=K-70S1oycR4

1:33…“10 years”.


Dive into the fascinating world of aging research with this thought-provoking video. Join us as we explore the latest breakthroughs and scientific advancements on the quest to reverse aging. Discover the potential strategies, therapies, and technologies that hold promise for extending healthspan and pushing the boundaries of human longevity. Get ready to embark on an exciting journey towards understanding the future of aging reversal.

Continue reading “How Long Until We Reverse the Clock? | Dr David Sinclair” »

Jul 1, 2023

Taking Rejuvenation to Longevity escape velocity: Aubrey De Grey [Aging & Gerontology 2023]

Posted by in category: life extension

At 19:46 Aubrey has a chart for 150 year olds and 1,000 year olds.


6th Edition: AGING & GERONTOLOGY — Sciinov Group.
www.agingcongress.com.

Continue reading “Taking Rejuvenation to Longevity escape velocity: Aubrey De Grey [Aging & Gerontology 2023]” »

Jul 1, 2023

How Finland managed to virtually end homelessness

Posted by in categories: biotech/medical, life extension, neuroscience, policy, transhumanism

I believe that homelessness is often seen in America or other parts of the world as bad but with Finland they have found a housing first approach which has stopped nearly all homelessness there. I believe also regenerative medicine and lots of transhumanistic approaches to medicine would help end their aging and even repair their body if needed. Also if we research the brain we can finally discover and repair genes throughout the body essentially bringing them back near perfect and beyond. Along with ethical approaches towards a more cultural relativistic approach to all humans could show everyone how to coexist. It is still a problem of aging though which is still curable and in extreme cases will be eventually solved in the future. I think with a more comprehensive understanding of all transhumansistic medicine it would be possible to save all lives so no one is left behind.


OK, so the Finns are more generous and just shell out a lot more to help the homeless, right? Actually not. The Finns are simply smarter.

Instead of abandoning the homeless, they housed them. And that led to an insight: people tend to function better when they’re not living on the street or under a bridge. Who would have guessed?

Continue reading “How Finland managed to virtually end homelessness” »

Jul 1, 2023

Breast cancer by age: Study reveals early mutations that predict patient outcomes

Posted by in categories: biotech/medical, genetics, life extension

A study led by researchers at Sanford Burnham Prebys has found that in young women, certain genetic mutations are associated with treatment-resistant breast cancer. These mutations are not linked to treatment-resistant breast cancer in older women. The findings, published in the journal Science Advances, could help improve precision medicine and suggest a brand-new way of classifying breast cancer.

“It’s well established that as you get older, you’re more likely to develop cancer. But we’re finding that this may not be true for all cancers depending on a person’s genetic makeup,” says senior author Svasti Haricharan, Ph.D., an assistant professor at Sanford Burnham Prebys. “There may be completely different mechanisms driving cancer in younger and older people, which requires adjusting our view of aging and cancer.”

The research primarily focused on ER+/HER2-, which is one of the most common forms of the disease. It is usually treated with hormonal therapies, but for some patients, these treatments don’t work. About 20% of tumors resist treatment from the very beginning, and up to 40% develop resistance over time.

Jun 30, 2023

Rapamycin — All You Need To Know & Get Started | Dr Ross Pelton Ep1

Posted by in categories: biotech/medical, life extension

And he mentions Internatioan Aging Systems where you can legally order Rapamycin but I would have to know what experience people have had with them and their product first myself.


Magnesium Breakthrough 10% Discount _https://bit.ly/3O5tPfu_ Code Modern10 This video brought to you by BiOptimizers.
Some links are affiliate links so we will earn a commission when they are used to purchase products.
In this video Pelton talks all about rapamycin, its history, how it works, dosage and timing. He also talks about where you can get rapamycin online.

Continue reading “Rapamycin — All You Need To Know & Get Started | Dr Ross Pelton Ep1” »

Jun 28, 2023

Activating Just One Gene to Rejuvenate Model Mice

Posted by in category: life extension

In a new study published in Aging Cell [1], researchers report that transient activation of the Yamanaka factor Oct4 allowed partial reprogramming of cells, which led to rejuvenation in these cells and in a mouse model of premature aging.

Jun 28, 2023

Oxygen restriction helps fast-aging lab mice live longer

Posted by in categories: biotech/medical, chemistry, life extension

For the first time, researchers have shown that reduced oxygen intake, or “oxygen restriction,” is associated with longer lifespan in lab mice, highlighting its anti-aging potential. Robert Rogers of Massachusetts General Hospital in Boston, US, and colleagues present these findings in a study published May 23rd in the open access journal PLOS Biology.

Research efforts to extend healthy lifespan have identified a number of chemical compounds and other interventions that show promising effects in mammalian lab animals— for instance, the drug metformin or . Oxygen restriction has also been linked to longer lifespan in yeast, nematodes, and fruit flies. However, its effects in mammals have been unknown.

To explore the anti-aging potential of oxygen restriction in mammals, Rogers and colleagues conducted lab experiments with mice bred to age more quickly than other mice while showing classic signs of mammalian aging throughout their bodies. The researchers compared the lifespans of mice living at normal atmospheric oxygen levels (about 21%) to the lifespans of mice that, at 4 weeks of age, had been moved to a living environment with a lower proportion of oxygen (11%—similar to that experienced at an altitude of 5,000 meters).

Jun 27, 2023

Rapamycin is the gold standard for longevity interventions

Posted by in categories: biotech/medical, life extension

It sucks that the primary reason this has not gone forward is because it is off patent.


This video is reproduced from a presentation I gave to the Euro-Geroscience Task Force “Challenges in Developing Geroscience Drug Trials” held March 23, 2022 in Toulouse, France. It gives an introduction to the state of research on rapamycin as a potential longevity and healthspan drug and some of the challenges and opportunities for clinical development.